Evidence map›Paper›PMID 28884327›Full record

ReviewCellular and molecular life sciences : CMLS2017

Introductory review: periostin-gene and protein structure.

Akira Kudo

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 68 citations in OpenAlex.

  1. Identification and characterization of POSTNJournal of orthopaedic translation · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Matricellular proteins: Potential biomarkers in head and neck cancer.Journal of cell communication and signaling · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. The role of periostin in cardiac fibrosis.Heart failure reviews · 2024
    Review
  14. Article
  15. Review
  16. Periostin: an emerging activator of multiple signaling pathways.Journal of cell communication and signaling · 2022
    Review
  17. Periostin: biology and function in cancer.Cancer cell international · 2022
    Review
  18. Article
  19. The Role of Matrix Proteins in Cardiac Pathology.International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Akira KudoInternational Frontier, Tokyo Institute of Technology, S3-8, 2-12-1 Oookayama, Meguro-ku, Tokyo, 152-8550, Japan. akudo@bio.titech.ac.jp.
Tokyo Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although many studies have described the role of periostin in various diseases, the function of the periostin protein structures derived from alternative splicing and proteinase cleavage at the C-terminal remain unknown. Further experiments revealing the protein structures that are highly related to diseases are essential to understand the function of periostin in depth, which would accelerate its clinical application by establishing new approaches for curing intractable diseases. Furthermore, this understanding would enhance our knowledge of novel functions of periostin related to stemness and response to mechanical stress.

Indexed as

Alternative SplicingAmino Acid SequenceAnimalsAsthmaCell Adhesion MoleculesExonsHumansIntronsMacular DegenerationMiceMyocardial InfarctionNeoplasmsOsteoblastsOsteogenesisProtein DomainsProtein IsoformsCell Adhesion MoleculesPOSTN protein, humanProtein IsoformsAlternative splicingfas 1 familyMatricellular proteinPeriostinProteinase cleavage

Identifiers

PMID28884327
PMCPMC11107487
OpenAlexW2752073206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.